Regulatory regimes such as the EU FMD and U.S. DSCSA drive serialization to strengthen visibility and oversight, but these ...
From KPI clarity to right-sized staffing, Kimberly Howard explains how to measure true FRM impact and build flexible models ...
Matt Sample breaks down the operational hurdles and strategies for transitioning to the FDA’s new 12-digit NDC format. While ...
In today's Pharma Pulse, the FDA grants expanded approval for Imcivree, while new research highlights how optimizing pharmacy ...
Jordan Armstrong outlines how adaptable DTP programs can reduce barriers and accelerate patient access to therapy. As ...
As global temperatures continue to rise and weather patterns grow more volatile, the pharmaceutical industry faces a mounting ...
Pharmaceutical manufacturers have historically relied on intermediaries—including pharmacy benefit managers (PBMs), ...
In today's Pharma Pulse, the FDA grants a 54-day fast-track approval for high-dose Wegovy under a new priority program while ...
PharmaKonnect and co-founder of Tina’s Warriors, discusses the biggest post therapy launch patient support gaps.
As manufacturers and stakeholders work to streamline patient access at therapy launch, a critical gap often persists in the ...
A $3 billion China investment targets localized oral solid-dose manufacturing and supply-chain redundancy to support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results